Product & Service News
Discover the latest product and service news. Stay informed about new product launches, service updates, market trends, and customer feedback across various industries. Get insights into innovations and developments driving market growth.
Apr 14, 2026 at 7:05 AM
Novigenix AI to Present Clinical Data at AACR 2026 Linking Immuno-Pharmacodynamics to Radioligand Therapy Response
EPALINGES, Switzerland--(BUSINESS WIRE)--Novigenix AI, a leader in AI-driven healthcare solutions, today announced the presentation of new data at the American Association for Cancer Research (AACR) 2026 Annual Meeting demonstrating, for the first time in a human clinical setting, the dynamic role of the immune system in response to radioligand therapy in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET).1 The study, conducted in collaboration with RadioMedix, Inc....
Apr 14, 2026 at 7:02 AM
Sophia Learning Partners with NurseDash to Support Healthcare Career Advancement
HERNDON, Va.--(BUSINESS WIRE)--Sophia Learning announces a partnership with NurseDash....
Apr 14, 2026 at 7:02 AM
DataVisor Launches the First Conversational AI Agents for Financial Crime Prevention
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DataVisor, the leading AI-powered fraud and AML platform, today announced Vera, the first suite of conversational AI agents for battling financial crime. Vera redefines how institutions manage risk: teams give instructions in plain language, and AI agents execute them across the entire fraud and AML lifecycle. By replacing time-intensive manual processes and workflows, it introduces a faster, more adaptive, and intelligent operating model built for the de...
Apr 14, 2026 at 7:01 AM
Promega Expands Forensic Portfolio with Distribution Agreement for NimaGen’s IDseek® MPS Library Prep Kits
MADISON, Wis.--(BUSINESS WIRE)--Promega will distribute NimaGen's IDseek® MPS library prep kits for forensic casework through a new distribution agreement with NimaGen....
Apr 14, 2026 at 7:00 AM
4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...
Apr 14, 2026 at 7:00 AM
Bobbie Launches 100% Organic Whole Milk Infant Formula at Target Nationwide
HEATH, Ohio--(BUSINESS WIRE)--Bobbie, the American-manufactured infant formula, announces its Organic Whole Milk Infant Formula is rolling onto Target shelves (in person and digitally) nationwide, making it the only American-made infant formula with no skim milk available to Target shoppers. The News: Starting mid-March 2026, Bobbie began rolling out its newly updated 100% organic whole milk infant formula recipe across full chain distribution at Target (1,900 stores). Pricing & Size: Avail...
Apr 14, 2026 at 7:00 AM
SS&C GlobeOp Hedge Fund Performance Index and Capital Movement Index
WINDSOR, Conn.--(BUSINESS WIRE)--SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the gross return of the SS&C GlobeOp Hedge Fund Performance Index for March 2026 measured -1.79%. Hedge fund flows as measured by the SS&C GlobeOp Capital Movement Index advanced 0.26% in April. "The 0.26% increase in SS&C GlobeOp's Capital Movement Index for April 2026 was notable, as flows for the period are generally negative from portfolio rebalancing," said Bill Stone, Chairman...
Apr 14, 2026 at 7:00 AM
Findings From Long-Term Analysis of the Effects of LYBALVI® (olanzapine and samidorphan) on Negative Symptoms of Schizophrenia Published in The Journal of Clinical Psychiatry
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced the publication of a 56-week post hoc analysis of the effects of LYBALVI® (olanzapine and samidorphan) on negative symptoms in adults living with schizophrenia in the peer-reviewed publication The Journal of Clinical Psychiatry. The analysis—titled “The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia”—found that treatment with LYBALVI was associat...
Apr 14, 2026 at 7:00 AM
FreeWheel Launches First-of-its-Kind Context Engine to Deliver Scaled, AI-Driven Contextual Targeting Globally Across Premium Video
NEW YORK--(BUSINESS WIRE)--FreeWheel Launches First-of-its-Kind Context Engine to Deliver Scaled, AI-Driven Contextual Targeting Globally Across Premium Video...
Apr 14, 2026 at 7:00 AM
ICON Launches ICON Prime, a Dedicated Government Division Focused on Military, Intelligence, and Space Applications to Accelerate Robotic Construction for National Security
AUSTIN, Texas--(BUSINESS WIRE)--ICON, the global leader in robotic construction technologies and large-scale 3D printing, announced today the launch of ICON Prime – a dedicated defense and space tech business unit focused on deploying ICON's robotic construction systems for the U.S. military and NASA. The new business unit allows ICON to focus efforts on the specialized needs and demands of efforts like modernizing military construction and developing robotic systems for delivering infrastructu...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.